ZA98300B - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
ZA98300B
ZA98300B ZA98300A ZA98300A ZA98300B ZA 98300 B ZA98300 B ZA 98300B ZA 98300 A ZA98300 A ZA 98300A ZA 98300 A ZA98300 A ZA 98300A ZA 98300 B ZA98300 B ZA 98300B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
ZA98300A
Other languages
English (en)
Inventor
John Fairhurst
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA98300B publication Critical patent/ZA98300B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA98300A 1997-01-17 1998-01-14 Pharmaceutical compounds ZA98300B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700895.7A GB9700895D0 (en) 1997-01-17 1997-01-17 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ZA98300B true ZA98300B (en) 1998-09-10

Family

ID=10806121

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98300A ZA98300B (en) 1997-01-17 1998-01-14 Pharmaceutical compounds

Country Status (29)

Country Link
US (1) US20010053783A1 (id)
EP (1) EP0854146B1 (id)
JP (1) JPH10204090A (id)
KR (1) KR20000070221A (id)
AR (1) AR011422A1 (id)
AT (1) ATE190617T1 (id)
AU (1) AU5569298A (id)
CA (1) CA2227132A1 (id)
CZ (1) CZ290318B6 (id)
DE (1) DE69800092T2 (id)
DK (1) DK0854146T3 (id)
EA (1) EA001469B1 (id)
ES (1) ES2144888T3 (id)
GB (1) GB9700895D0 (id)
GR (1) GR3033316T3 (id)
HU (1) HUP0000854A3 (id)
ID (1) ID21920A (id)
IL (1) IL129647A (id)
NO (1) NO993372L (id)
NZ (1) NZ335493A (id)
PE (1) PE99399A1 (id)
PL (1) PL334569A1 (id)
PT (1) PT854146E (id)
SI (1) SI0854146T1 (id)
SV (1) SV1998000088A (id)
TR (1) TR199901583T2 (id)
TW (1) TW396156B (id)
WO (1) WO1998031686A1 (id)
ZA (1) ZA98300B (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999010346A1 (en) * 1997-08-22 1999-03-04 Eli Lilly And Company Limited Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
GB9825413D0 (en) * 1998-11-19 1999-01-13 Lilly Co Eli Pharmaceutical compounds
GB9903784D0 (en) * 1999-02-18 1999-04-14 Lilly Co Eli Pharmaceutical compounds
AR028945A1 (es) * 2000-06-19 2003-05-28 Lundbeck & Co As H Derivados de indol
KR101165996B1 (ko) 2010-04-23 2012-07-18 주식회사 녹십자 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
CN105949190B (zh) * 2016-07-04 2018-06-29 烟台凯博医药科技有限公司 一种制备1,8-萘啶及衍生物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
JPH10204090A (ja) 1998-08-04
EP0854146A1 (en) 1998-07-22
NO993372D0 (no) 1999-07-08
HUP0000854A3 (en) 2002-06-28
WO1998031686A1 (en) 1998-07-23
CZ290318B6 (cs) 2002-07-17
IL129647A (en) 2002-02-10
TW396156B (en) 2000-07-01
NZ335493A (en) 2000-09-29
DE69800092D1 (de) 2000-04-20
NO993372L (no) 1999-07-08
CZ151099A3 (cs) 1999-09-15
SV1998000088A (es) 2000-10-10
IL129647A0 (en) 2000-02-29
GB9700895D0 (en) 1997-03-05
EA001469B1 (ru) 2001-04-23
ES2144888T3 (es) 2000-06-16
SI0854146T1 (en) 2000-10-31
PL334569A1 (en) 2000-03-13
AR011422A1 (es) 2000-08-16
EP0854146B1 (en) 2000-03-15
CA2227132A1 (en) 1998-07-17
PT854146E (pt) 2000-08-31
EA199900667A1 (ru) 2000-02-28
US20010053783A1 (en) 2001-12-20
DK0854146T3 (da) 2000-06-05
ID21920A (id) 1999-08-12
KR20000070221A (ko) 2000-11-25
DE69800092T2 (de) 2000-09-14
GR3033316T3 (en) 2000-09-29
AU5569298A (en) 1998-08-07
TR199901583T2 (xx) 1999-11-22
ATE190617T1 (de) 2000-04-15
HUP0000854A2 (hu) 2000-11-28
PE99399A1 (es) 1999-11-11

Similar Documents

Publication Publication Date Title
GB9700504D0 (en) Pharmaceutical compounds
GB9602080D0 (en) Pharmaceutical compounds
GB9817118D0 (en) Pharmaceutical compounds
PL340337A1 (en) Drugs
GB9817623D0 (en) Pharmaceutical compounds
GB9706089D0 (en) Pharmaceutical composition
SG76535A1 (en) Pharmaceutical agents
EG22250A (en) Novel pharmaceutical compound
GB9810886D0 (en) Pharmaceutical compounds
EP1003495A4 (en) PHARMACEUTICAL COMPOUNDS
GB9726566D0 (en) Novel pharmaceutical
GB9609976D0 (en) Pharmaceutical compounds
GB9716244D0 (en) Pharmaceutical compounds
EG23694A (en) Novel pharmaceutical
GB9621789D0 (en) Pharmaceutical compounds
GB9717428D0 (en) Pharmaceutical composition
GB9823847D0 (en) Pharmaceutical compounds
EP0923564A4 (en) PHARMACEUTICAL COMPOUNDS
GB9823845D0 (en) Pharmaceutical compounds
ZA979329B (en) Pharmaceutical compounds
GB9700895D0 (en) Pharmaceutical compounds
GB9626151D0 (en) Pharmaceutical compounds
GB9817197D0 (en) Pharmaceutical compounds
GB2321190B (en) Pharmaceutical composition
GB9706376D0 (en) Novel pharmaceutical